Trevi Therapeutics, Inc.
NASDAQ:TRVI · NASDAQ Global Market
+$0.43 today
Vol 2.90M · Avg 1.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+199.30%
Period High
$17.21
Period Low
$5.47
Latest
$17.21
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Zymeworks Inc.
NASDAQ:ZYME
$1.67B
Novavax, Inc.
NASDAQ:NVAX
$1.54B
Ardelyx, Inc.
NASDAQ:ARDX
$1.45B
Precigen, Inc.
NASDAQ:PGEN
$1.41B
Tourmaline Bio, Inc.
TRML
$1.23B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.16B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$882.50M
Zenas BioPharma, Inc.
NASDAQ:ZBIO
$845.09M
Upstream Bio, Inc.
NASDAQ:UPB
$338.45M
What is the latest TRVI filing?
The latest filing shown is 4 dated Jun 4, 2026.
How many recent filings does TRVI have?
Intrinsic Alpha currently shows 20 recent filings for TRVI.
Explore More
Continue the stock analysis
Jump to another research area for this company.